Bleeding occurring in the second half of pregnancy causes important maternal and infant morbidity and even mortality; at the Instituto Nacional Materno Perinatal it compromises between 9 and 15% of all gestations. We recall it is associated to premature delivery, abruption placenta, placenta previa, disseminated intravascular coagulation. Treatment frequently requires blood and blood derivates transfusions as well as performing surgical procedures, including emergency hysterectomy. This is a review of second half of pregnancy hemorrhage causes; we emphasize precocious diagnosis and timely treatment of these pathologies.

Bleeding occurring in the second half of pregnancy causes important maternal and infant morbidity and even mortality; at the Instituto Nacional Materno Perinatal it compromises between 9 and 15% of all gestations. We recall it is associated to premature delivery, abruption placenta, placenta previa, disseminated intravascular coagulation. Treatment frequently requires blood and blood derivates transfusions as well as performing surgical procedures, including emergency hysterectomy. This is a review of second half of pregnancy hemorrhage causes; we emphasize precocious diagnosis and timely treatment of these pathologies.

La preeclampsia es una complicación seria de la gestación y es una de las principales causas de mortalidad materna y perinatal en el Perú y en el mundo. Por largo tiempo se ha intentado uniformizar criterios diagnósticos, lo cual haga factible comparar estudios de investigación con respecto a los trastornos hipertensivos en el embarazo. Se realizó un estudio observacional, descriptivo, retrospectivo. Se revisaron las historias clínicas de las pacientes quienes tuvieron su parto entre los meses de octubre a diciembre del 2004 en el Instituto Nacional Materno Perinatal de Lima, quienes presentaban algún diagnóstico de trastorno hipertensivo durante su ingreso al ser hospitalizadas o al momento del alta. Se obtuvo una incidencia de trastornos hipertensivos del embarazo del 5.13%, y de preeclampsia de 3.25%, en el INMP en este periodo. Se observó que del total de pacientes evaluada...

Rounds for patient safety is a recommended practice to increase the quality of clinical and non-clinical services involved in patient care. It consists of planned visits of the relevant executive staff in order to establish direct relationship with personnel and patients with an educational attitude and with the general objective to strengthen the culture of patient safety. In the Instituto Nacional Materno Perinatal, a category III-2 establishment specialized in the care of women, pregnant women and newborns, these rounds have been in practice since 2011, and improvements in safe care for patients have been obtained. We present the experience of the Institute between years 2011 and 2017.

Objectives. Determine the level of user satisfaction in outpatient gynecology. Materials and methods. Observational, descriptive, retrospective and cross-sectional study. Survey structured for 126 patients ranging from 19-65 years old attended in Outpatient Gynecology at the National Maternal and Perinatal Institute.

Objectives. Determine the level of user satisfaction in outpatient gynecology. Materials and methods. Observational, descriptive, retrospective and cross-sectional study. Survey structured for 126 patients ranging from 19-65 years old attended in Outpatient Gynecology at the National Maternal and Perinatal Institute.

Objective. Misoprostol is an analogous of Prostaglandin E1, used for induction of labor when Bishop score is lower than 6. The goal of the study is to describe la eficacy of 25 μg vaginal misoprostol to induction of labor in term gestantions with live fetus. Also describe others outcomes like way of delivery, characteristics of newborn, adverse maternal and perinatal outcomes. Materials and methods. Descriptive and retrospective study. Population: pregnant women hospitalized in Obstetrics C Unit at Instituto Nacional Materno Perinatal for induction of labor with vaginal misoprostol. Period: may 2009 to march 2010. Data in SPSS version 13 to statistics analysis. Results. 25 μg vaginal misoprostol each 6 hours was administrated to 39 pregnants. Mean age was 27 years. Gestacional age 40 weeks (between 37 to 42). 51% was nulliparous, 92% pregnants had Bishop score lower than 5. It is achie...

Objective. Misoprostol is an analogous of Prostaglandin E1, used for induction of labor when Bishop score is lower than 6. The goal of the study is to describe la eficacy of 25 μg vaginal misoprostol to induction of labor in term gestantions with live fetus. Also describe others outcomes like way of delivery, characteristics of newborn, adverse maternal and perinatal outcomes. Materials and methods. Descriptive and retrospective study. Population: pregnant women hospitalized in Obstetrics C Unit at Instituto Nacional Materno Perinatal for induction of labor with vaginal misoprostol. Period: may 2009 to march 2010. Data in SPSS version 13 to statistics analysis. Results. 25 μg vaginal misoprostol each 6 hours was administrated to 39 pregnants. Mean age was 27 years. Gestacional age 40 weeks (between 37 to 42). 51% was nulliparous, 92% pregnants had Bishop score lower than 5. It is achie...

Emergency oral contraception based on levonorgestrel prevents pregnancy by preventing or delaying ovulation. The factual medical-legal analysis based on the judicial ruling regarding compliance in the health facilities is performed to guarantee the delivery of the emergency oral contraception pill to the patients, otherwise the precautionary measure has not been effective in ensuring delivery of the medication and in other cases barriers to its dispensation have been observed.

Emergency oral contraception based on levonorgestrel prevents pregnancy by preventing or delaying ovulation. The factual medical-legal analysis based on the judicial ruling regarding compliance in the health facilities is performed to guarantee the delivery of the emergency oral contraception pill to the patients, otherwise the precautionary measure has not been effective in ensuring delivery of the medication and in other cases barriers to its dispensation have been observed.

Objective: To describe the prevalence and characteristics of seropositive pregnant women for SARS-CoV-2. Material and methods: Quantitative, cross-sectional and descriptive study. Performed in pregnant women screened for SARS-CoV-2 who met selection criteria at hospital admission. Variables of maternal characteristics, pregnancy complications and newborn condition were collected from the respective medical history. Data analysis was performed using descriptive statistics and 95% confidence intervals. Results: 1477 pregnant women admitted to hospitalization were screened, identifying a seroprevalence of anti-SARS-CoV-2 antibodies in 5.28% (95% CI: 4.22% -6.57%). Among the cases of positive seroprevalence, IgM 11.5% (95% CI: 5.7% -21.3%), IgM / IgG 64.1% (95% CI: 5.7% -21.3%), IgG 19% (95% CI: 15.7% and 35.6) were observed %), 91% of seropositive pregnant women were asymptomatic, 40% of se...

Objective: To describe the prevalence and characteristics of seropositive pregnant women for SARS-CoV-2. Material and methods: Quantitative, cross-sectional and descriptive study. Performed in pregnant women screened for SARS-CoV-2 who met selection criteria at hospital admission. Variables of maternal characteristics, pregnancy complications and newborn condition were collected from the respective medical history. Data analysis was performed using descriptive statistics and 95% confidence intervals. Results: 1477 pregnant women admitted to hospitalization were screened, identifying a seroprevalence of anti-SARS-CoV-2 antibodies in 5.28% (95% CI: 4.22% -6.57%). Among the cases of positive seroprevalence, IgM 11.5% (95% CI: 5.7% -21.3%), IgM / IgG 64.1% (95% CI: 5.7% -21.3%), IgG 19% (95% CI: 15.7% and 35.6) were observed %), 91% of seropositive pregnant women were asymptomatic, 40% of se...

Introduction: COVID-19 disease spreads rapidly. Seroprevalence in pregnant women entering for hospitalization and clinical characteristics in this type of population in Peru is not known. Objective: To determine the prevalence and clinical-epidemiological characteristics of pregnant women with anti-SARS-CoV-2 antibodies at a level III hospital in Peru. Methods: Observational and cross-sectional study performed at the National Maternal Perinatal Institute of Peru. Pregnant women admitted for hospitalization were screened for COVID-19 infection. Results of anti-SARSCoV-2 serological tests and information on maternal and perinatal characteristics were obtained. Data analysis was performed using descriptive statistics and 95% confidence intervals. Results: In 2 419 pregnant women screened we identified a prevalence of 7.0% of anti-SARS-CoV-2 antibodies (95% IC: 6.1% to 8.1%), including IgM i...

Introducción. La enfermedad de COVID-19 se propaga rápidamente. Se desconoce la seroprevalencia en mujeres embarazadas que ingresan a hospitalización y sus características propias en este tipo de población en Perú. Objetivo. Determinar la prevalencia y características clínico-epidemiológicas de gestantes con anticuerpos anti-SARS-CoV-2 en un hospital nivel III de Perú. Métodos. Estudio observacional de tipo transversal, realizado en el Instituto Nacional Materno Perinatal de Perú, entre el 15 de abril y 15 de mayo de 2020. Participaron todas las gestantes que ingresaron a hospitalización y fueron tamizadas para la infección por SARS-CoV-2 mediante pruebas serológicas, cuyos resultados fueron analizados conjuntamente con sus características clínicas y epidemiológicas, utilizando estadígrafos descriptivos e intervalos de confianza al 95%, y mediante la prueba de independ...

Introduction. In Peru, hypertensive disorders of pregnancy are the second cause of maternal mortality. Objective. This evidence-based clinical practice guideline (EB-CPG) provides recommendations for the prevention and treatment of pre-eclampsia and eclampsia. Methods. An adapted EB-CPG was elaborated through a systematic, rigorous and transparent process with a group consisting of methodologists and health professionals who are experts in the management of the disease. The guide has sixteen clinical questions and sixteen recommendations. The search and pre-selection of EB-CPGs were performed, which were evaluated through the “Appraisal of Guidelines for Research and Evaluation II” tool (AGREE-II), for its adaptation. The systematic search for evidence to answer the 16 clinical questions were made in multiple databases: MEDLINE / PubMed, EMBASE / Ovid, C...